Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00417924 · ClinicalTrials.gov registry record · Early Phase 1

Eye on Diabetes: A Multidisciplinary Patient Education Intervention

A Early Phase 1 study, sponsored by Nova Southeastern University.

Completed
Registry status
Early Phase 1
Development phase
90
Enrollment target

NCT00417924: Completed Early Phase 1 study, sponsored by Nova Southeastern University.

NCT00417924 is a Early Phase 1 study that has completed, run by Nova Southeastern University. The registered enrollment target is 90 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (70% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00417924, a Early Phase 1 study, has completed, sponsored by Nova Southeastern University.

COMPLETED
Registry status
Early Phase 1
Development phase
90 participants
Enrollment target

Study Summary

Vision loss from diabetes is often preventable with timely detection and treatment. Patients with diabetes may not understand the importance of annual dilated eye examinations or recognize the benefits of early detection of diabetic eye disease. The proposed research project compares usual eye care to eye care emphasizing patient education for adult patients with diabetes.

Interventions

  • BEHAVIORAL Patient education

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2004-10
Est. Completion 2005-10
Phase Early Phase 1
Nova Southeastern University

71 total trials

What the finished NCT00417924 record still lists

NCT00417924 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (70% higher).

The record links to 0 conditions, and to 1 intervention - of which Patient education is the first listed.

NCT00417924 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00417924 about?

NCT00417924 is a clinical study titled "Eye on Diabetes: A Multidisciplinary Patient Education Intervention". Vision loss from diabetes is often preventable with timely detection and treatment. Patients with diabetes may not understand the importance of annual dilated eye examinations or recognize the benefits of early detection of diabetic eye disease. The proposed research project compares usual eye care ...

What is the current status of trial NCT00417924?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 90 participants. The study started on 2004-10. Estimated completion is 2005-10.

What interventions are being tested in trial NCT00417924?

The interventions under investigation include: Patient education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00417924?

This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00417924's enrollment target sits among peer trials

90 233rd of 2000 higher than 1,753 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00417924, the US trial registry maintained by the National Library of Medicine. NCT00417924 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.